Merck & Company Inc (MRK) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Merck & Co., Inc. operates as a healthcare company worldwide.

Total Revenue Chart for Merck & Company Inc

Merck & Company Inc (MRK) revenue for FY2025 was USD 64.9B, a 1.2% change from FY2024. Merck & Company Inc's revenue grew from USD 3.5B in 1985 to USD 64.9B in 2025 (1730.2% over 40 years). Earnings per share grew from USD 2.90 in 2000 to USD 7.28 in 2025 (151.2%). Revenue compound annual growth rate: 5-year CAGR of 9.4%, 10-year CAGR of 5.1%, 20-year CAGR of 5.6%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$361.02B
Implied Share Price
$146.33
Enterprise Value
$394.46B
Revenue (TTM)
$66.57B
EBITDA
$28.87B
Profit Margin
4.77%
Trailing P/E
116.13
Forward P/E
15.02
Price/Book (MRQ)
8.29
Price/Sales (TTM)
5.42
EV/EBITDA
27.38
EV/Revenue
5.93
Dividend Yield
2.36%
Book Value
$16.99
Free Cash Flow (FY2025)
$12.36B
Free Cash Flow Yield
3.42%

Snapshot as of 30th October 2026 — not point-in-time controlled, may lag the live market by a few days.